Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site Sort ascending
  • Standort
  • Division
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Sort ascending Standort Division Business Functional Area Erscheinungsdatum
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
District Manager Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Jun 05, 2024
Manager-Retail National Key Account Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Jul 04, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Der Umsatz Okt 17, 2024
Manufacturing Specialist Changping County (Beijing) China Operations Innovative Medicines Technical Operations Apr 26, 2024
Equipment Engineer Changping County (Beijing) China Operations Innovative Medicines Technical Operations Mai 21, 2024
Equipment Operator Changping County (Beijing) China Operations Innovative Medicines Technical Operations Jun 13, 2024
First Line Manager / District Manager Changchun (Jilin Province) China International Innovative Medicines Der Umsatz Okt 09, 2024
Territory Business Executive Chandigarh (Territory) Indien International Innovative Medicines Der Umsatz Okt 14, 2024
Sr. Automation Engineer Carlsbad USA Operations CTS Research & Development Aug 02, 2024
Clinical Laboratory Scientist, Generalist Carlsbad USA Operations Innovative Medicines Research & Development Mai 17, 2024
Head of Quality Carlsbad USA Operations Innovative Medicines Quality Sep 03, 2024
Senior Automation Engineer Carlsbad USA Operations CTS Technical Operations Mai 01, 2024
Quality Assurance Specialist II Carlsbad USA Operations Innovative Medicines Quality Okt 02, 2024
Production Manager Carlsbad USA Operations Innovative Medicines Technical Operations Okt 11, 2024
Associate Project Manager – Clinical Trials Carlsbad USA Operations Innovative Medicines BD&L & Strategic Planning Okt 22, 2024
Project Manager – Clinical Trials Carlsbad USA Operations Innovative Medicines BD&L & Strategic Planning Okt 22, 2024
Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 02, 2024
Research Scientist, Cell Pharmacology - CVM Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Okt 16, 2024
Cardiologist Physician Scientist (Associate Director/Director) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 05, 2024
Associate Director / Director Biotherapeutics (Dual Posting) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 08, 2024
Research Scientist - Lab Technician (Dual Posting) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 26, 2024
Senior Scientist, Functional Genomics, Screening & Automation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 27, 2024
Asset Strategy Lead – Automation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 27, 2024
Asset Strategy Lead – Biologics Analysis Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 27, 2024
Senior Scientist, Chemistry (BS or MS) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 30, 2024
Research Scientist, Chemistry (BS or MS) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 30, 2024
Therapeutic Area Head PKS (Global Health) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Compound Management, Liquid Handling Automation Operator Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Manager, Health, Safety and Environment Cambridge (USA) USA Operations CTS Einrichtungen und Verwaltung Sep 04, 2024
Associate Director/Director PK Sciences - Oncology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 06, 2024
Global Head Neuroscience Translational Medicine Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 09, 2024
Principal Scientist – Covalency & Exploratory Chemical Biology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 15, 2024
Senior Scientist, Oncology Pathology & Biomarkers Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 15, 2024
Principle Scientist, Molecular Imaging Expert Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 18, 2024
Senior Automation Engineer – Laboratory Automation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 20, 2024
Senior Clinical Sciences Trial Leader (Global Health) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 22, 2024
Principal Scientist, Modeling & Simulation RLT Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Senior Principal Scientist/Associate Director, Radioligand Modeling & Simulation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Principal /Senior Principal Scientist PKS Oncology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Mai 20, 2024
HSE Facilities Maintenances Specialist Cambridge (USA) USA Operations CTS Einrichtungen und Verwaltung Mai 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.